article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

Working in the CRO and CDMO environment she has led projects for customers across the globe, helping them to achieve their goals in clinical trials and low volume commercial manufacture. Petra holds a D.Phil in synthetic organic chemistry and am MBA from Imperial College London. 2022 Nov 14 [cited 2023 Apr 6];40(11):1255–63.

article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

On Day 1, Tuesday 14 November 2023, the tracks include: Display of biologics, antibody-based cancer therapies, safety and efficacy of bispecific antibodies, modulating the tumour microenvironment, optimisation and developability, and cell line and systems engineering. from engineered peptide and antibody libraries’.